Hem › Lupus
Kliniska studier för Lupus som rekryterar i USA
73 studier för Lupus rekryterar deltagare vid platser över hela USA.
Städer med flest studier
- New York City, NY18 studier
- Houston, TX13 studier
- Durham, NC12 studier
- Miami, FL10 studier
- Washington, DC10 studier
- Tampa, FL9 studier
- Philadelphia, PA9 studier
- Clearwater, FL8 studier
- Chicago, IL8 studier
- Boston, MA8 studier
- Santa Monica, CA8 studier
- Los Angeles, CA8 studier
- Buena Park, CA7 studier
- Plantation, FL7 studier
- Memphis, TN7 studier
- Charlotte, NC7 studier
- San Diego, CA7 studier
- Oklahoma City, OK7 studier
- Dallas, TX6 studier
- Aurora, CO6 studier
- Hollywood, FL6 studier
- Cedar Rapids, IA6 studier
- Atlanta, GA6 studier
- Fullerton, CA5 studier
- Lake Charles, LA5 studier
- Cicero, IL5 studier
- Jackson, TN5 studier
- St. Louis, MO5 studier
- New Orleans, LA5 studier
- Syracuse, NY5 studier
- Orlando, FL5 studier
- Cleveland, OH5 studier
- Flint, MI4 studier
- Frisco, TX4 studier
- San Francisco, CA4 studier
- Charleston, SC4 studier
- Salt Lake City, UT4 studier
- Kansas City, KS4 studier
- Louisville, KY4 studier
- Phoenix, AZ4 studier
Efter delstat
- Alabama5 studier
- Arizona7 studier
- Colorado8 studier
- District of Columbia5 studier
- Florida23 studier
- Georgia9 studier
- Illinois14 studier
- Indiana4 studier
- Iowa6 studier
- Kalifornien27 studier
- Kansas5 studier
- Kentucky4 studier
- Louisiana9 studier
- Maryland10 studier
- Massachusetts9 studier
- Michigan10 studier
- Minnesota5 studier
- Missouri8 studier
- Nebraska3 studier
- New Jersey6 studier
- New York26 studier
- North Carolina20 studier
- Ohio11 studier
- Oklahoma7 studier
- Pennsylvania14 studier
- South Carolina5 studier
- Tennessee13 studier
- Texas26 studier
- Utah4 studier
- Virginia3 studier
- Washington5 studier
Nyligen uppdaterade studier
Officiell studietext (engelska)
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
RekryterarFas 3
Ålder 12 till 100 · Alla kön · Uppdaterad 1 okt. 2026 · NCT06133972Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
RekryterarFas 2
Ålder 18 till 100 · Alla kön · Uppdaterad 1 okt. 2026 · NCT05268289A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
RekryterarFas 2
Ålder 18 till 74 · Alla kön · Uppdaterad 1 okt. 2026 · NCT07409181An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
RekryterarFas 3
Ålder 5 till 17 · Alla kön · Uppdaterad 30 sep. 2026 · NCT05835310Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
RekryterarObservationsstudie
Ålder 18 till 120 · Kvinnor · Uppdaterad 28 sep. 2026 · NCT05567198A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
RekryterarFas 3
Ålder 18 till 70 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07430306A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07438496A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
RekryterarFas 1
Ålder 18 till 75 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07607964CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
RekryterarFas 1/2
Ålder 10 till 29 · Alla kön · Uppdaterad 24 sep. 2026 · NCT06839976Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT03816345Anifrolumab Pregnancy Study
RekryterarObservationsstudie
Ålder 18 till 130 · Kvinnor · Uppdaterad 18 sep. 2026 · NCT07049653The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 18 sep. 2026 · NCT05440422Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
RekryterarFas 1
Ålder 18 till 65 · Alla kön · Uppdaterad 18 sep. 2026 · NCT07201558Transcutaneous Vagus Nerve Stimulation in SLE
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 17 sep. 2026 · NCT06987565A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
RekryterarFas 2
Ålder 16 till 70 · Alla kön · Uppdaterad 17 sep. 2026 · NCT07328581Study of Systemic Lupus Erythematosus
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 3 till 120 · Alla kön · Uppdaterad 16 sep. 2026 · NCT00001372Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users
RekryterarFas 4
Ålder 18 till 130 · Kvinnor · Uppdaterad 16 sep. 2026 · NCT06594068HEALTH Home Urinalysis Testing
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 16 sep. 2026 · NCT07823478A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
RekryterarFas 1
Ålder 18 till 70 · Alla kön · Uppdaterad 15 sep. 2026 · NCT06916806A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 14 sep. 2026 · NCT07355218Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
RekryterarFas 1
Ålder 18 till 60 · Alla kön · Uppdaterad 14 sep. 2026 · NCT06975787A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
RekryterarFas 2
Ålder 12 till 70 · Alla kön · Uppdaterad 14 sep. 2026 · NCT07570862A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 11 sep. 2026 · NCT07332481A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
RekryterarFas 1
Ålder 18 till 74 · Alla kön · Uppdaterad 10 sep. 2026 · NCT07085104A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
RekryterarFas 1/2
Ålder 18 till 70 · Alla kön · Uppdaterad 10 sep. 2026 · NCT06897930Från ClinicalTrials.gov, data hämtad 2 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.